Affiliation:
1. Cancer Center and Department of Molecular Pharmacology and Experimental Therapeutics (M.D., K.H., D.I.P., L.J.M.), Mayo Clinic, Scottsdale, Arizona 85259;
2. Commonwealth Biotechnologies, Inc. (N.M.), Richmond, Virginia 23235
Abstract
AbstractUnderstanding of the conformational changes in G protein-coupled receptors associated with activation and inactivation is of great interest. We previously used photoaffinity labeling to elucidate spatial approximations between photolabile residues situated throughout the pharmacophore of secretin agonist probes and this receptor. The aim of the current work was to develop analogous photolabile secretin antagonist probes and to explore their spatial approximations. The most potent secretin antagonist reported is a pseudopeptide ([ψ4, 5]secretin) in which the peptide bond between residues 4 and 5 was replaced by a ψ(CH2-NH) peptide bond isostere. We have developed a series of [ψ4, 5]secretin analogs incorporating photolabile benzoyl phenylalanine residues in positions 6, 22, and 26. Each bound to the secretin receptor saturably and specifically, with affinity similar to their parental peptide. At concentrations with no measurable agonist activity, each probe covalently labeled the secretin receptor. Peptide mapping using proteolytic cleavage, immunoprecipitation, and radiochemical sequencing identified that each of these three probes labeled the amino terminus of the secretin receptor. Whereas the position 22 probe labeled the same residue as its analogous agonist probe and the position 6 probe labeled a residue within two residues of that labeled by its analogous agonist probe, the position 26 probe labeled a site 16 residues away from that labeled by its analogous agonist probe. Thus, whereas structurally related agonist and antagonist probes dock in the same general region of this receptor, conformational differences in active and inactive states result in substantial differences in spatial approximation at the carboxyl-terminal end of secretin analogs.
Subject
Endocrinology,Molecular Biology,General Medicine
Reference44 articles.
1. G protein-coupled receptors. I. Diversity of receptor-ligand interactions.;Ji;J Biol Chem,1998
2. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagons-like peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family.;Segre;Trends Endocrinol Metab,1993
3. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.;Ulrich II;Gastroenterology,1998
4. Molecular pharmacology of the secretin receptor.;Dong;Receptors Channels,2002
5. Parathyroid hormone 1 receptor: insights into structure and function.;Chorev;Receptors Channels,2002
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献